Industry News

US senator: Legislation possible if industry dislikes FDA rules for CBD

An Oregon legislator instrumental in legalizing hemp in 2018 says Congress can always create laws to regulate CBD if the industry isn’t happy with the rules from the U.S. Food and Drug Administration.

An Oregon legislator instrumental in legalizing hemp in 2018 says Congress can always create laws to regulate CBD if the industry isn’t happy with the rules from the U.S. Food and Drug Administration.

Sen. Ron Wyden, a Democrat, blamed the FDA for stifling the growth of the CBD market during a speech Thursday to the American Herbal Products Association.

He boasted that Oregon is one of the largest hemp-producing states.

“However, as you all know far too well, the FDA continues to make it difficult to produce and sell CBD products,” Wyden said.Last month, the FDA submitted its draft rules for CBD oversight to the White House Office of Management and Budget, which must approve new regulations from any federal agency.

The draft rules, called “Cannabidiol Enforcement Policy Draft Guidance for Industry,” do not have a date set for public release.

“We all are hoping that we will see sensible, discretion(ary) enforcement from that,” Wyden said.

“Depending on what the FDA does, I believe that we always have the option of going forward with legislation.”

Read: Full Story on Hemp Industry Daily

To Top